Evidence map›Paper›PMID 24314662›Full record

ArticleVirology2014

Methylation of human papillomavirus 16, 18, 31, and 45 L2 and L1 genes and the cellular DAPK gene: Considerations for use as biomarkers of the progression of cervical neoplasia.

Mina Kalantari, Kathryn Osann, Itzel E Calleja-Macias, Seong Kim, Bing Yan, Sara Jordan, Dana M Chase, Krishnansu S Tewari, Hans-Ulrich Bernard

Abstract read
In one paragraph

Article in Virology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Epigenetic approaches for cervical neoplasia screening (Review).Experimental and therapeutic medicine · 2021
    Review
  6. Article
  7. Article
  8. Methylation in Predicting Progression of Untreated High-grade Cervical Intraepithelial Neoplasia.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020
    Article
  9. Article
  10. Identification ofFrontiers in genetics · 2018
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Determination of malignant potential of cervical intraepithelial neoplasia.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mina KalantariDepartment of Dermatology, University of California Irvine, Irvine, CA 92697, United States.
Kathryn Osann
Itzel E Calleja-Macias
Seong Kim
Bing Yan
Sara Jordan
Dana M Chase
Krishnansu S Tewari
Hans-Ulrich Bernard

Funding

Univ.of Calif., Irvine Cancer Center Support GrantP30CA062203 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI Christine Hui · 1994 to 2026
$57.9M
NCI NIH HHS P30 CA062203
6 · The paper itself

Abstract

During progression of cervical cancer, human papillomavirus genomes and cellular tumor suppressor genes can become methylated. Toward a better understanding of these biomarkers, we studied 104 samples with HPV16, 18, 31, and 45 representing five pathological categories from asymptomatic infection to cancer. We grouped all samples by HPV type and pathology and measured the overall methylation of informative amplicons of HPV late genes and the cellular DAPK gene. Methylation of all four HPV types as well as of the DAPK gene is lowest in asymptomatic infection and increases successively in all four pathological categories during progression to cancer. 27 out of 28 cancer samples showed methylation both in the L2/L1 genes as well as in DAPK, but a much lower fraction in all other pathological categories. We discuss the problem to develop diagnostic tests based on complex methylation patterns that make it difficult to classify amplicons as "methylated" or "unmethylated".

Indexed as

AlphapapillomavirusBiomarkers, TumorDeath-Associated Protein KinasesDisease ProgressionDNA MethylationFemaleHuman papillomavirus 16Human papillomavirus 18Human papillomavirus 31HumansOncogene Proteins, ViralPapillomavirus InfectionsPromoter Regions, GeneticUterine Cervical DysplasiaUterine Cervical NeoplasmsBiomarkers, TumorDAPK1 protein, humanDeath-Associated Protein KinasesOncogene Proteins, ViralBiomarkerCancer progressionDAPK geneDNA methylationEpigeneticsPapillomaviruses

Identifiers

PMID24314662
PMCPMC4051423

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.